In addition, studies have shown that the incretin hormone, glucagon-like peptide-1, which has antidiabetic properties, can play a neuroprotective role in the brain and has demonstrated promising effects in animal models of AD and PD (Hölscher, 2014; Batista et al., 2019). This evidence concerns the gene GCG and Parkinson disease.